CLINICAL AND PHARMACOKINETIC EFFECTS OF A DIET RICH IN INSOLUBLE FIBER ON PARKINSON DISEASE

被引:87
作者
ASTARLOA, R [1 ]
MENA, MA [1 ]
SANCHEZ, V [1 ]
DELAVEGA, L [1 ]
DEYEBENES, JG [1 ]
机构
[1] RAMON & CAJAL HOSP,DEPT INVEST,MADRID,SPAIN
关键词
PARKINSONS DISEASE; L-DOPA PHARMACOKINETICS; FIBER INTAKE;
D O I
10.1097/00002826-199210000-00004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In this study, the effects of a diet rich in insoluble fiber (DRIF) on motor disability and the peripheral pharmacokinetics of orally administered L-dopa in Parkinsonian patients with marked constipation are analyzed. We found a useful effect of a DRIF on plasma L-dopa concentration and motor function. The greatest effect on the plasma L-dopa levels was found early (at 30 and 60 min) after oral administration. There was a relationship between the improvement of constipation and the higher bioavailability Of L-dopa. DRIF can be a coadjutant treatment in patients with Parkinson's disease.
引用
收藏
页码:375 / 380
页数:6
相关论文
共 18 条
  • [1] [Anonymous], 1987, RECENT DEV PARKINSON
  • [2] BARTHOLINI G, 1972, J PHARMACOL EXP THER, V183, P65
  • [3] A BALANCED CARBOHYDRATE - PROTEIN-DIET IN THE MANAGEMENT OF PARKINSONS-DISEASE
    BERRY, EM
    GROWDON, JH
    WURTMAN, JJ
    CABALLERO, B
    WURTMAN, RJ
    [J]. NEUROLOGY, 1991, 41 (08) : 1295 - 1297
  • [4] A DATA-BASED APPROACH TO DIET QUESTIONNAIRE DESIGN AND TESTING
    BLOCK, G
    HARTMAN, AM
    DRESSER, CM
    CARROLL, MD
    GANNON, J
    GARDNER, L
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1986, 124 (03) : 453 - 469
  • [5] DUJOVNE CA, 1970, GASTROENTEROLOGY, V58, P1039
  • [6] GASTROINTESTINAL SYMPTOMS IN PARKINSONS-DISEASE
    EDWARDS, LL
    PFEIFFER, RF
    QUIGLEY, EMM
    HOFMAN, R
    BALLUFF, M
    [J]. MOVEMENT DISORDERS, 1991, 6 (02) : 151 - 156
  • [7] 3-0-METHYLDOPA AND MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE
    FABBRINI, G
    JUNCOS, JL
    MOURADIAN, MM
    SERRATI, C
    CHASE, TN
    [J]. NEUROLOGY, 1987, 37 (05) : 856 - 859
  • [8] GERVAS JJ, 1983, NEUROLOGY, V33, P278, DOI 10.1212/WNL.33.3.278
  • [9] GIBALDI M, 1984, BIOPHARMACEUTICS CLI
  • [10] PARKINSONISM - ONSET PROGRESSION AND MORTALITY
    HOEHN, MM
    YAHR, MD
    [J]. NEUROLOGY, 1967, 17 (05) : 427 - &